imatinib mesylate has been researched along with Allergic Encephalomyelitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adzemovic, MV; Adzemovic, MZ; Eriksson, U; Nilsson, I; Olsson, T; Zeitelhofer, M | 1 |
| Azizi, G; Haidari, MR; Javanbakht, MH; Khorramizadeh, M; Mirshafiey, A; Naddafi, F; Sadria, R; Sedaghat, R; Tofighi Zavareh, F | 1 |
| Crespo, O; Daneman, R; Ho, PP; Kang, SC; Lindstrom, TM; Robinson, WH; Sobel, RA; Steinman, L | 1 |
3 other study(ies) available for imatinib mesylate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Topics: Animals; Benzamides; Blood-Brain Barrier; Brain; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Imatinib Mesylate; Inflammation; Multiple Sclerosis; Neurons; Peptides; Piperazines; Pyrimidines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Receptors, CCR2; Signal Transduction; Spinal Cord; T-Lymphocytes | 2013 |
Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Imatinib Mesylate; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2014 |
Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
Topics: Animals; Anisoles; Astrocytes; Benzamides; Benzenesulfonates; Cell Differentiation; Cell Proliferation; Cells, Cultured; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Imatinib Mesylate; Macrophages; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Receptors, Platelet-Derived Growth Factor; Sorafenib; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2011 |